Releasing a model based on a hacking super-weapon raised alarm in Washington, which responded with fatal export controls. Nervy allies have new reason to build non-US rivals and fret over chokepoint tech. The $965 bln lab’s IPO hopes risk falling into a regulatory Pandora’s box.
